title: Ensuring the safe and effective use of medications during pregnancy: planning and prevention through preconception care.
authors.affiliation: National Center on Birth Defects and Developmental Disabilities, Centers for Disease Control and Prevention, MS E-86, 1600 Clifton Road, N.E., Atlanta, Georgia 30333, USA. jcragan@cdc.gov
authors.forename: Janet D
authors.initials: JD
authors.lastname: Cragan
authors.forename: J M
authors.initials: JM
authors.lastname: Friedman
authors.forename: Lewis B
authors.initials: LB
authors.lastname: Holmes
authors.forename: Kathleen
authors.initials: K
authors.lastname: Uhl
authors.forename: Nancy S
authors.initials: NS
authors.lastname: Green
authors.forename: Laura
authors.initials: L
authors.lastname: Riley
mesh_terms: D000014:Abnormalities, Drug-Induced / Q000517:prevention & control*; D018927:Anti-Asthmatic Agents / Q000008:administration & dosage / Q000009:adverse effects; D000927:Anticonvulsants / Q000008:administration & dosage / Q000009:adverse effects; D001249:Asthma / Q000188:drug therapy; D064420:Drug-Related Side Effects and Adverse Reactions; D004827:Epilepsy / Q000188:drug therapy; D005260:Female; D006801:Humans; D015474:Isotretinoin / Q000008:administration & dosage / Q000009:adverse effects; D010347:Patient Care Planning; D016742:Preconception Care; D011247:Pregnancy; D011248:Pregnancy Complications / Q000517:prevention & control*; D011256:Pregnancy Outcome; D011295:Prenatal Care; D012306:Risk; D013723:Teratogens
chemical_list: D018927:Anti-Asthmatic Agents; D000927:Anticonvulsants; D013723:Teratogens; D015474:Isotretinoin